Literature DB >> 29896676

EBV-Encoded Latent Genes.

Teru Kanda1.   

Abstract

Epstein-Barr virus (EBV) is one of the most widespread human pathogens. EBV infection is usually asymptomatic, and it establishes life-long latent infection. EBV latent infection sometimes causes various tumorigenic diseases, such as EBV-related lymphoproliferative diseases, Burkitt lymphomas, Hodgkin lymphomas, NK/T-cell lymphomas, and epithelial carcinomas. EBV-encoded latent genes are set of viral genes that are expressed in latently infected cells. They include virally encoded proteins, noncoding RNAs, and microRNAs. Different latent gene expression patterns are noticed in different types of EBV-infected cells. Viral latent gene products contribute to EBV-mediated B cell transformation and likely contribute to lymphomagenesis and epithelial carcinogenesis as well. Many biological functions of viral latent gene products have been reported, making difficult to understand a whole view of EBV latency. In this review, we will focus on latent gene functions that have been verified by genetic experiments using EBV mutants. We will also summarize how viral latent genes contribute to EBV-mediated B cell transformation, Burkitt lymphomagenesis, and epithelial carcinogenesis.

Entities:  

Keywords:  Burkitt lymphoma; EBNA; Epithelial carcinogenesis; LMP; Latent genes; microRNA

Mesh:

Substances:

Year:  2018        PMID: 29896676     DOI: 10.1007/978-981-10-7230-7_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  Phase separation of Epstein-Barr virus EBNA2 protein reorganizes chromatin topology for epigenetic regulation.

Authors:  Yiting Yang; Xidong Ye; Ranran Dai; Zhaoqiang Li; Yan Zhang; Wei Xue; Yongchang Zhu; Delong Feng; Litao Qin; Xin Wang; Bo Lei; Shixiu Liao; Bingtao Hao
Journal:  Commun Biol       Date:  2021-08-16

2.  Triptolide inhibits human telomerase reverse transcriptase by downregulating translation factors SP1 and c-Myc in Epstein-Barr virus-positive B lymphocytes.

Authors:  Cong Long; Qiu-Bo Xu; Li Ding; Liu Yang; Wei Ji; Feng Gao; Yong Ji
Journal:  Oncol Lett       Date:  2021-02-10       Impact factor: 2.967

Review 3.  The roles of ribosomal proteins in nasopharyngeal cancer: culprits, sentinels or both.

Authors:  Edmund Ui-Hang Sim; Choon-Weng Lee; Kumaran Narayanan
Journal:  Biomark Res       Date:  2021-06-30

Review 4.  Deletion of Viral microRNAs in the Oncogenesis of Epstein-Barr Virus-Associated Lymphoma.

Authors:  Hiroshi Kimura; Yusuke Okuno; Yoshitaka Sato; Takahiro Watanabe; Takayuki Murata
Journal:  Front Microbiol       Date:  2021-07-08       Impact factor: 5.640

Review 5.  Epstein-Barr virus strain variation and cancer.

Authors:  Teru Kanda; Misako Yajima; Kazufumi Ikuta
Journal:  Cancer Sci       Date:  2019-02-21       Impact factor: 6.716

Review 6.  Epstein barr virus encodes miRNAs to assist host immune escape.

Authors:  Weiming Li; Cong He; Jiayi Wu; Dazhi Yang; Weihong Yi
Journal:  J Cancer       Date:  2020-02-03       Impact factor: 4.207

7.  Modification of Nuclear Compartments and the 3D Genome in the Course of a Viral Infection.

Authors:  S V Razin; A A Gavrilov; O V Iarovaia
Journal:  Acta Naturae       Date:  2020 Oct-Dec       Impact factor: 1.845

Review 8.  Nutraceutical Curcumin with Promising Protection against Herpesvirus Infections and Their Associated Inflammation: Mechanisms and Pathways.

Authors:  Miroslava Šudomová; Sherif T S Hassan
Journal:  Microorganisms       Date:  2021-01-31

Review 9.  Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation.

Authors:  Takayuki Murata; Atsuko Sugimoto; Tomoki Inagaki; Yusuke Yanagi; Takahiro Watanabe; Yoshitaka Sato; Hiroshi Kimura
Journal:  Viruses       Date:  2021-11-23       Impact factor: 5.048

Review 10.  Nanotechnology Frontiers in γ-Herpesviruses Treatments.

Authors:  Marisa Granato
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.